These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26903265)

  • 21. Immune response to racotumomab in a child with relapsed neuroblastoma.
    Sampor C; Guthmann MD; Scursoni A; Cacciavillano W; Torbidoni A; Galluzzo L; Camarero S; Lopez J; de Dávila MT; Fainboim L; Chantada GL
    Front Oncol; 2012; 2():195. PubMed ID: 23267436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Come forth 1E10 anti-idiotype vaccine: delivering the promise to immunotherapy of small cell lung cancer.
    Manjili MH
    Cancer Biol Ther; 2007 Feb; 6(2):151-2. PubMed ID: 17426436
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.
    Scursoni AM; Galluzzo L; Camarero S; Lopez J; Lubieniecki F; Sampor C; Segatori VI; Gabri MR; Alonso DF; Chantada G; de Dávila MT
    Clin Dev Immunol; 2011; 2011():245181. PubMed ID: 21941577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.
    López-Requena A; Bestagno M; Mateo de Acosta C; Cesco-Gaspere M; Vázquez AM; Pérez R; Burrone OR
    Mol Immunol; 2007 Apr; 44(11):2915-22. PubMed ID: 17316805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients.
    Guthmann MD; Castro MA; Cinat G; Venier C; Koliren L; Bitton RJ; Vázquez AM; Fainboim L
    J Immunother; 2006; 29(2):215-23. PubMed ID: 16531822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine.
    Carr A; Rodríguez E; Arango Mdel C; Camacho R; Osorio M; Gabri M; Carrillo G; Valdés Z; Bebelagua Y; Pérez R; Fernández LE
    J Clin Oncol; 2003 Mar; 21(6):1015-21. PubMed ID: 12637465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
    Fernández LE; Alonso DF; Gomez DE; Vázquez AM
    Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
    Labrada M; Clavell M; Bebelagua Y; León Jd; Alonso DF; Gabri MR; Veloso RC; Vérez V; Fernández LE
    Expert Opin Biol Ther; 2010 Feb; 10(2):153-62. PubMed ID: 20088712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
    López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R
    Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy.
    Uskent N; Ayla S; Molinas Mandel N; Ozkan M; Teomete M; Baloglu H; Aydıncer C; Yergok H; Dogan E; Berk B; Yazar A
    J Oncol; 2020; 2020():1360431. PubMed ID: 32670370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.
    Herrera ZM; Ramos TC
    Cancer Immunol Immunother; 2014 Jul; 63(7):737-47. PubMed ID: 24777612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenetic analysis of variable regions encoding AB1 and gamma-type AB2 antibodies from the NeuGc-containing ganglioside family.
    Perez A; Lombardero J; Mateo C; Mustelier G; Alfonso M; Vazquez AM; Perez R
    Hybridoma; 2001 Aug; 20(4):211-21. PubMed ID: 11604106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
    Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
    Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody.
    Fernández-Marrero Y; Hernández T; Roque-Navarro L; Talavera A; Moreno E; Griñán T; Vázquez AM; de Acosta CM; Pérez R; López-Requena A
    Mol Immunol; 2011 Apr; 48(8):1059-67. PubMed ID: 21306777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside.
    Rodríguez M; Llanes L; Pérez A; Pérez R; Vázquez AM
    Hybrid Hybridomics; 2003 Oct; 22(5):307-14. PubMed ID: 14678648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
    Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer].
    Wang S; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):682-686. PubMed ID: 27760599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.